Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 6 studies | 24% ± 6% | |
endothelial cell | 4 studies | 23% ± 5% | |
ciliated cell | 4 studies | 23% ± 5% | |
astrocyte | 4 studies | 26% ± 9% | |
epithelial cell | 3 studies | 25% ± 3% | |
GABAergic neuron | 3 studies | 34% ± 4% | |
glutamatergic neuron | 3 studies | 43% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1346.72 | 245 / 245 | 100% | 8.72 | 500 / 502 |
brain | 99% | 885.47 | 2628 / 2642 | 100% | 8.00 | 704 / 705 |
breast | 100% | 1324.95 | 459 / 459 | 99% | 8.16 | 1109 / 1118 |
adrenal gland | 100% | 1079.45 | 258 / 258 | 99% | 10.87 | 228 / 230 |
lung | 100% | 1192.04 | 577 / 578 | 99% | 7.42 | 1145 / 1155 |
esophagus | 100% | 1162.98 | 1445 / 1445 | 99% | 7.64 | 181 / 183 |
thymus | 100% | 1477.83 | 653 / 653 | 99% | 7.85 | 597 / 605 |
uterus | 100% | 1680.04 | 170 / 170 | 98% | 8.98 | 450 / 459 |
bladder | 100% | 1482.00 | 21 / 21 | 98% | 7.38 | 494 / 504 |
pancreas | 99% | 729.78 | 326 / 328 | 98% | 6.52 | 174 / 178 |
kidney | 100% | 813.22 | 89 / 89 | 96% | 6.02 | 862 / 901 |
intestine | 100% | 1563.22 | 966 / 966 | 95% | 5.97 | 503 / 527 |
ovary | 100% | 1726.27 | 180 / 180 | 94% | 4.70 | 405 / 430 |
stomach | 100% | 1121.68 | 359 / 359 | 93% | 5.46 | 266 / 286 |
skin | 100% | 1382.01 | 1808 / 1809 | 85% | 6.18 | 401 / 472 |
liver | 99% | 603.20 | 224 / 226 | 75% | 3.22 | 305 / 406 |
spleen | 100% | 1226.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.66 | 1 / 1 |
blood vessel | 100% | 1265.19 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1168.99 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 806.80 | 847 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 493.65 | 787 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 6.44 | 28 / 29 |
peripheral blood | 60% | 598.14 | 554 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 48% | 2.42 | 38 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007098 | Biological process | centrosome cycle |
GO_0010457 | Biological process | centriole-centriole cohesion |
GO_0007099 | Biological process | centriole replication |
GO_0005814 | Cellular component | centriole |
GO_0005813 | Cellular component | centrosome |
GO_0030496 | Cellular component | midbody |
GO_0000922 | Cellular component | spindle pole |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0008017 | Molecular function | microtubule binding |
Gene name | CEP44 |
Protein name | Centrosomal protein of 44 kDa (Cep44) (HBV PreS1-transactivated protein 3) (PS1TP3) Centrosomal protein of 44 kDa |
Synonyms | KIAA1712 |
Description | FUNCTION: Centriole-enriched microtubule-binding protein involved in centriole biogenesis. In collaboration with CEP295 and POC1B, is required for the centriole-to-centrosome conversion by ensuring the formation of bona fide centriole wall . Functions as a linker component that maintains centrosome cohesion. Associates with CROCC and regulates its stability and localization to the centrosome . . |
Accessions | ENST00000505124.5 ENST00000503780.6 [Q9C0F1-1] ENST00000503053.5 D6RGX6 ENST00000396791.7 [Q9C0F1-1] Q9C0F1 D6RC25 ENST00000515299.5 ENST00000514712.5 D6RBX1 ENST00000457424.6 [Q9C0F1-2] ENST00000426172.3 [Q9C0F1-2] ENST00000296519.6 [Q9C0F1-1] |